Encompass Health Corp. announced it was recently awarded a certificate of need by the Illinois Health Facilities and Services Review Board to build a 40-bed inpatient rehabilitation hospital in Shiloh, Illinois. The hospital is expected to operate as a joint venture between Encompass Health and BJC HealthCare. The parties anticipate the future hospital will be located adjacent to BJC HealthCare's Memorial East campus on Frank Scott Parkway East.   Complementing local acute

Leading health care system Prime Healthcare and leading health and well-being company Humana Inc. (NYSE: HUM) today announced agreements that provide in-network access for most area Humana Medicare Advantage and commercial plan members at two Prime Healthcare hospitals in Kansas. Now in effect, the agreements add in-network access for local Humana Medicare Advantage Preferred Provider Organization (PPO), Private Fee-for-Service (PFFS), and Health Maintenance Organization (HMO) plan

Business Wire IndiaMerck Foundation marks World Science DayMerck Foundation, the philanthropic arm of Merck KGaA Germany, marks

CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended September 30, 2020. Summary of Third Quarter 2020 Financial Results and Recent Accomplishments

Indicating a substantial recovery from the impact of COVID-19, Total Net Revenue (“Revenue”) was $291.8 million in the third quarter of 2020, a sequential increase of 53.1% from the second quarter of 2020 and a decrease of only 0.3% from last year’s third quarter of $292.7 million

SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following November investor conferences. Stifel 2020 Virt

Innovative Phase 2b/3 NASH-RX Trial in NASH Cirrhosis Initiated Board Member Joel Lewis Assumes CEO Role – Board Adds Two New Highly Accomplished Professionals NORCROSS, Ga., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the lead

ProTec 99 is the solution for quick and affordable sterilization in a wide variety of areas. This patent-pending product employs proprietary technology in a handheld device that allows the user to scan surfaces while emitting powerful UV-C radiation. When used correctly, ProTec 99 is a simple, safe, and effective method for disinfection that attenuates 99.99% of viruses from replicating, including coronavirus. While we are currently facing the threat of Covid-19, it remains a fact t

InControl Medical, LLC today announced that the Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized the Company to be a Medicare Provider. InControl Medical is now included in the Medicare Supplier Directory at Medicare.gov, and this designation allows InControl Medical to bill Medicare directly when it delivers its Attain device in 42 states and Washington D.C. Herschel “Buzz” Peddicord, President and CEO, s

Johnson & Johnson will hold a virtual Medical Devices Update for the investment community on Thursday, November 19, 2020, in which leadership will focus on the Company's differentiated and competitive platforms across digital surgery and provide franchise and innovation highlights across the Johnson & Johnson Medical Devices Companies. "We look forward to providing an update on the strength of our Medical Devices business and how we are positioning ourselves for lon